Skip to main content
Advertisement
Advertisement

INM

INM logo

InMed Pharmaceuticals Inc. Common Shares

1.40
USD
Sponsored
+0.02
+1.45%
Sep 24, 15:59 UTC -4
Closed
exchange

Pre-Market

1.40

0.00
0.00%

INM Earnings Reports

Positive Surprise Ratio

INM beat 2 of 7 last estimates.

29%

Next Report

Today
Date of Next Report
Sep 21, 2026
Estimate for Q4 26 (Revenue/ EPS)
--
/
--
Implied change from Q-- -- (Revenue/ EPS)
--
/
--
Implied change from Q4 25 (Revenue/ EPS)
--
/
--

InMed Pharmaceuticals Inc. Common Shares earnings per share and revenue

On --, INM reported earnings of -- USD per share (EPS) for -- --, -- the estimate of -- USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a --% difference.
Looking ahead to Q4 26, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
PharmaCyte Biotech, Inc. Common Stock
Report Date
Sep 14, 2026 For Q1 27
Estimate
-
Actual
-$0.54
Surprise
-
FAQ
For Q-- --, InMed Pharmaceuticals Inc. Common Shares reported EPS of --, Inline estimates by --, and revenue of --, -- -- expectations.
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
The next earning report is scheduled for Sep 21, 2026.
Based on -- analysts, InMed Pharmaceuticals Inc. Common Shares is expected to report EPS of -- and revenue of -- for Q4 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement